World AIDS Day: Bulgaria's AIDS profile Sofia Echo, Bulgaria - Of the patients on HAART, 70 per cent were infected heterosexually, 21 per cent MSM, three per cent IDUs, three per cent MTCT and two per cent were ...
Survival, plasma HIV-1 RNA concentrations and drug resistance in ... World Health Organization (press release), Switzerland - Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: week 60 results from the ...
Adherence Issues in the Treatment of Hepatitis B Medscape - Nov 24, 2008 In HIV infection, adherence to highly active antiretroviral therapy (HAART) is an important modifiable risk factor in the development of drug-resistant ...
You and Your Health Nigerian Tribune, Nigeria - Nov 28, 2008 Finally, patients developing diabetes mellitus while on anti-HIV drugs, are at increased risk of complications of diabetes including diseases of the eyes, ...
Delaying HIV treatment can be deadly pride source.com, MI - Nov 21, 2008 Those who deferred starting HAART had a 70 percent greater risk of death than patients who began therapy. "These data strongly support the use of ...
HIV protection: Could pills work wonders against HIV? (Feature) Monsters and Critics.com - Nov 27, 2008 Researchers have concluded that patients on HAART therapy are less infectious, and believe the same pills might protect someone who is not yet infected. ...
Stem cell transplant in a patient with HIV and AML HemOncToday, NJ - Nov 12, 2008 Of particular interest was that this patient was HIV-positive and on highly active antiretroviral therapy or HAART prior to transplant, and that his donor ...
High rate of death amongst patients with HIV diagnosed late Aidsmap, UK - Nov 20, 2008 ... to be at risk of HIV infection are required.? Mussini C. et al. Patients presenting with AIDS in the HAART era: a collaborative cohort analysis. ...
Could treatment interruptions make a comeback? Aidsmap, UK - Nov 11, 2008 CD4-guided STI in patients responding to HAART. Ninth International Congress on Drug Therapy in HIV Infection, Glasgow. Abstract O213. 2008. ...
Source: Google News
Recent News and Articles on the Keywords: patients receiving + risk + patients Related to the article below (Last Update: 8/7/2008)
Exercise Lowers Risk of Colon Cancer U.S. News & World Report, DC - Several factors may contribute to this lack of knowledge about the link between exercise and colon cancer risk. "Patients may not be learning this ...
Nephrotoxic Effects in High-Risk Patients Undergoing Angiography - P Aspelin, P Aubry, SG Fransson, R Strasser, R … - New England Journal of Medicine, 2003 - content.nejm.org ... No patientreceiving iodixanol had an increase of 1.0 mg per deciliter or more,
but 10 patients in the ... likely to develop in high-riskpatients when iodixanol ...
Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical … - A Khan, SR Khan, RM Leventhal, WA Brown - The International Journal of Neuropsychopharmacology, 2001 - Cambridge Univ Press ... The overall risk was 6345\100000 per year (108\1702.0); among patientsreceiving
in- vestigational antidepressants, 6294\100000 per year (95\1509.3); and among ...
Tuberculosis, a risk for patients receiving HAART therapy
People taking highly active antiretroviral therapy ( HAART ) for HIV infection remain susceptible to tuberculosis, though the risk is lower than for HIV-infected patients not on HAART.
The study is published in the Clinical Infectious Diseases.
Opportunistic infections such as tuberculosis can be fatal for immunocompromised patients.
HAART not only reduces the viral load of HIV, but it also often helps to keep other infections such as TB under control.
In fact, previous studies indicate that HAART can reduce the risk of tuberculosis in HIV patients by 70 to 90 percent.
Although HIV-infected people living in industrialized nations are at lower risk of tuberculosis than those living in resource-poor countries, it continues to be a significant problem for HIV-infected people everywhere.
A group of European and American researchers followed patients with HIV for three years after they began HAART.
The rate of tuberculosis was highest within the first three months of therapy, but declined after longer HAART exposure.
Patients’ risk of developing tuberculosis more than doubled if HAART did not successfully control their HIV.
Patients were also more likely to develop tuberculosis if they were more immunodeficient when they started taking HAART.
HIV-infected patients from industrialized nations might develop tuberculosis if they were exposed to the tuberculosis organism in the past, especially for those emigrating from resource-poor countries.
Their weakened immune status can allow reactivation of latent tuberculosis infection, according to lead author Enrico Girardi, of the Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani in Rome.
But they don’t necessarily have to leave the country to contract tuberculosis.
HIV-infected American and European patients who are “exposed to someone with tuberculosis, for example in a hospital setting, are at increased risk of acquiring tuberculosis infection and of developing active tuberculosis within a short time, usually six months to one year,” Girardi said.
Since tuberculosis is a potentially deadly opportunistic infection for patients with HIV, doctors need to be aware of the risk and take certain precautionary measures. “ HIV-infected patients, even when treated with HAART, remain at increased risk of developing tuberculosis,” Girardi said.
“ Thus, physicians caring for patients with HIV should continue to screen for and to treat latent tuberculosis infection in their patients, even if they have minor levels of immune suppression or are successfully treated with HAART.” Health care settings should also maintain strict control measures to prevent the spread of tuberculosis to patients being treated for HIV, Girardi added.
Source: Infectious Diseases Society of America, 2005
